Showing results (421-430 of 446) with videos related to
Sort By:
Pageof 45
Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.Diabetes, Obesity & Metabolism|July 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care datasetHannah Wallace, James Wick, Brendon L Neuen, et al.Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.American Heart Journal|August 25, 2024
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trialChao Jiang, Zhiyan Wang, Xin Du, et al.Heart (British Cardiac Society)|June 30, 2018
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trialsVanessa Selak, Ruth Webster, Sandrine Stepien, et al.Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.Eclinicalmedicine|July 18, 2019
Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysisDanni Zheng, Ying Xu, Shoujiang You, et al.Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.Pageof 45